GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eastwood Bio-Medical Canada EBM.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

1.84

+2.22%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$782,080

FY2016FY2025

Net income

−C$332,767

FY2016FY2025

Free cash flow

C$19,303

FY2016FY2025

Shareholders' equity

−C$1.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$782,080C$702,076C$867,936C$1.3mC$981,051C$718,336C$1.3mC$743,973C$479,729C$463,933
Operating income−C$292,328−C$437,700−C$506,040−C$128,760−C$590,895−C$838,656−C$563,792−C$565,929−C$586,205−C$507,495
Net income−C$332,767−C$455,870−C$546,598−C$160,584−C$611,336−C$860,030−C$579,677−C$861,977−C$489,624−C$468,479
Diluted earnings per share-0.00-0.01-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$218,772C$274,293C$489,137C$584,534C$691,123C$933,378C$1.6mC$2.3mC$2.8mC$3.2m
Cash and short-term investments——C$18,448C$39,839C$20,868C$122,656C$625,350C$826,590C$1.3mC$1.5m
Total liabilitiesC$1.8mC$1.6mC$1.3mC$878,732C$835,442C$474,104C$335,732C$361,414C$55,755C$35,565
Debt——C$23,083C$62,250C$31,350C$23,211—C$979——
Shareholders' equity−C$1.6m−C$1.3m−C$840,796−C$294,198−C$144,319C$459,274C$1.3mC$1.9mC$2.8mC$3.2m
Shares outstanding69m69m69m69m69m69m69m69m69m67m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsC$19,303−C$15,217−C$16,888−C$4,294−C$116,214−C$542,694−C$178,129−C$454,790−C$355,279−C$306,577
Capital spending———−C$3,005−C$5,574−C$5,574−C$23,111−C$23,111−C$23,111−C$23,111
Free cash flowC$19,303−C$15,217−C$16,888−C$7,299−C$121,788−C$548,268−C$201,240−C$477,901−C$378,390−C$329,688

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
RevenueC$149,792C$144,978C$152,224C$365,122—C$76,782C$214,720C$177,614
Operating income−C$66,245−C$64,343−C$40,453−C$36,550−C$60,003−C$155,586−C$40,190−C$138,432
Net income−C$67,586−C$66,380−C$20,726−C$76,869−C$57,809−C$156,898−C$41,188−C$155,944
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assetsC$256,960C$265,381C$250,990C$218,772C$216,800C$235,602C$203,923C$274,293
Cash and short-term investments————C$22,000———
Debt————C$71,300———
Shareholders' equity−C$1.8m−C$1.7m−C$1.7m−C$1.6m−C$1.6m−C$1.5m−C$1.3m−C$1.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-15.6%1.7%-4.1%
Operating income31.4%-19.0%0.1%
Net income27.5%-17.3%2.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-49.2%-37.4%-52.2%-55.7%
Net margin-53.1%-41.0%-55.4%-59.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-104.8-18.1-1.3-7.9-0.9-1.0-1.8-2.7
Price to sales44.611.70.81.00.61.20.83.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.